Skip to main content
Top
Published in: Critical Care 1/2022

01-12-2022 | Septicemia | Research

Identifying clinical subtypes in sepsis-survivors with different one-year outcomes: a secondary latent class analysis of the FROG-ICU cohort

Authors: Sabri Soussi, Divya Sharma, Peter Jüni, Gerald Lebovic, Laurent Brochard, John C. Marshall, Patrick R. Lawler, Margaret Herridge, Niall Ferguson, Lorenzo Del Sorbo, Elodie Feliot, Alexandre Mebazaa, Erica Acton, Jason N. Kennedy, Wei Xu, Etienne Gayat, Claudia C. Dos Santos, the FROG-ICU, CCCTBG trans-trial group study for InFACT - the International Forum for Acute Care Trialists

Published in: Critical Care | Issue 1/2022

Login to get access

Abstract

Background

Late mortality risk in sepsis-survivors persists for years with high readmission rates and low quality of life. The present study seeks to link the clinical sepsis-survivors heterogeneity with distinct biological profiles at ICU discharge and late adverse events using an unsupervised analysis.

Methods

In the original FROG-ICU prospective, observational, multicenter study, intensive care unit (ICU) patients with sepsis on admission (Sepsis-3) were identified (N = 655). Among them, 467 were discharged alive from the ICU and included in the current study. Latent class analysis was applied to identify distinct sepsis-survivors clinical classes using readily available data at ICU discharge. The primary endpoint was one-year mortality after ICU discharge.

Results

At ICU discharge, two distinct subtypes were identified (A and B) using 15 readily available clinical and biological variables. Patients assigned to subtype B (48% of the studied population) had more impaired cardiovascular and kidney functions, hematological disorders and inflammation at ICU discharge than subtype A. Sepsis-survivors in subtype B had significantly higher one-year mortality compared to subtype A (respectively, 34% vs 16%, p < 0.001). When adjusted for standard long-term risk factors (e.g., age, comorbidities, severity of illness, renal function and duration of ICU stay), subtype B was independently associated with increased one-year mortality (adjusted hazard ratio (HR) = 1.74 (95% CI 1.16–2.60); p = 0.006).

Conclusions

A subtype with sustained organ failure and inflammation at ICU discharge can be identified from routine clinical and laboratory data and is independently associated with poor long-term outcome in sepsis-survivors.

Graphical Abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.CrossRefPubMedPubMedCentral Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.CrossRefPubMedPubMedCentral
2.
go back to reference Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72:1491–501.CrossRefPubMedPubMedCentral Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72:1491–501.CrossRefPubMedPubMedCentral
3.
go back to reference Mankowski RT, Yende S, Angus DC. Long-term impact of sepsis on cardiovascular health. Intensive Care Med. 2019;45:78–81.CrossRefPubMed Mankowski RT, Yende S, Angus DC. Long-term impact of sepsis on cardiovascular health. Intensive Care Med. 2019;45:78–81.CrossRefPubMed
4.
go back to reference Prescott HC, Iwashyna TJ, Blackwood B, Calandra T, Chlan LL, Choong K, et al. Understanding and enhancing sepsis survivorship. Priorities for research and practice. Am J Respir Crit Care Med. 2019;200:972–81.CrossRefPubMedPubMedCentral Prescott HC, Iwashyna TJ, Blackwood B, Calandra T, Chlan LL, Choong K, et al. Understanding and enhancing sepsis survivorship. Priorities for research and practice. Am J Respir Crit Care Med. 2019;200:972–81.CrossRefPubMedPubMedCentral
5.
go back to reference Shankar-Hari M, Saha R, Wilson J, Prescott HC, Harrison D, Rowan K, et al. Rate and risk factors for rehospitalisation in sepsis survivors: systematic review and meta-analysis. Intensive Care Med. 2020;46:619–36.CrossRefPubMedPubMedCentral Shankar-Hari M, Saha R, Wilson J, Prescott HC, Harrison D, Rowan K, et al. Rate and risk factors for rehospitalisation in sepsis survivors: systematic review and meta-analysis. Intensive Care Med. 2020;46:619–36.CrossRefPubMedPubMedCentral
7.
go back to reference Mostel Z, Perl A, Marck M, Mehdi SF, Lowell B, Bathija S, et al. Post-sepsis syndrome—an evolving entity that afflicts survivors of sepsis. Mol Med. 2019;26:6.CrossRefPubMedPubMedCentral Mostel Z, Perl A, Marck M, Mehdi SF, Lowell B, Bathija S, et al. Post-sepsis syndrome—an evolving entity that afflicts survivors of sepsis. Mol Med. 2019;26:6.CrossRefPubMedPubMedCentral
8.
go back to reference Zhang Z, Zhang G, Goyal H, Mo L, Hong Y. Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysis. Crit Care. 2018;22:347.CrossRefPubMedPubMedCentral Zhang Z, Zhang G, Goyal H, Mo L, Hong Y. Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysis. Crit Care. 2018;22:347.CrossRefPubMedPubMedCentral
9.
go back to reference Seymour CW, Kennedy JN, Wang S, Chang C-CH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for Sepsis. JAMA. 2019;321:2003–17.CrossRefPubMedPubMedCentral Seymour CW, Kennedy JN, Wang S, Chang C-CH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for Sepsis. JAMA. 2019;321:2003–17.CrossRefPubMedPubMedCentral
10.
go back to reference Wiersema R, Jukarainen S, Vaara ST, Poukkanen M, Lakkisto P, Wong H, et al. Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery. Crit Care. 2020;24:150.CrossRefPubMedPubMedCentral Wiersema R, Jukarainen S, Vaara ST, Poukkanen M, Lakkisto P, Wong H, et al. Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery. Crit Care. 2020;24:150.CrossRefPubMedPubMedCentral
11.
go back to reference Yende S, Kellum JA, Talisa VB, Peck Palmer OM, Chang C-CH, Filbin MR, et al. Long-term host immune response trajectories among hospitalized patients with sepsis. JAMA Netw Open. 2019;2:e198686.CrossRefPubMedPubMedCentral Yende S, Kellum JA, Talisa VB, Peck Palmer OM, Chang C-CH, Filbin MR, et al. Long-term host immune response trajectories among hospitalized patients with sepsis. JAMA Netw Open. 2019;2:e198686.CrossRefPubMedPubMedCentral
12.
go back to reference Reddy K, Sinha P, O’Kane CM, Gordon AC, Calfee CS, McAuley DF. Subphenotypes in critical care: translation into clinical practice. Lancet Respir Med. 2020;8:631–43.CrossRefPubMed Reddy K, Sinha P, O’Kane CM, Gordon AC, Calfee CS, McAuley DF. Subphenotypes in critical care: translation into clinical practice. Lancet Respir Med. 2020;8:631–43.CrossRefPubMed
13.
go back to reference Mebazaa A, Casadio MC, Azoulay E, Guidet B, Jaber S, Levy B, et al. Post-ICU discharge and outcome: rationale and methods of the The French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study. BMC Anesthesiol. 2015;15:143.CrossRefPubMedPubMedCentral Mebazaa A, Casadio MC, Azoulay E, Guidet B, Jaber S, Levy B, et al. Post-ICU discharge and outcome: rationale and methods of the The French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study. BMC Anesthesiol. 2015;15:143.CrossRefPubMedPubMedCentral
14.
go back to reference Gayat E, Cariou A, Deye N, Vieillard-Baron A, Jaber S, Damoisel C, et al. Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study. Crit Care. 2018;22:8.CrossRefPubMedPubMedCentral Gayat E, Cariou A, Deye N, Vieillard-Baron A, Jaber S, Damoisel C, et al. Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study. Crit Care. 2018;22:8.CrossRefPubMedPubMedCentral
15.
go back to reference Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12:1500–24.CrossRefPubMed Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12:1500–24.CrossRefPubMed
16.
go back to reference Bastian K, Hollinger A, Mebazaa A, Azoulay E, Féliot E, Chevreul K, et al. Association of social deprivation with 1-year outcome of ICU survivors: results from the FROG-ICU study. Intensive Care Med. 2018;44:2025–37.CrossRefPubMedPubMedCentral Bastian K, Hollinger A, Mebazaa A, Azoulay E, Féliot E, Chevreul K, et al. Association of social deprivation with 1-year outcome of ICU survivors: results from the FROG-ICU study. Intensive Care Med. 2018;44:2025–37.CrossRefPubMedPubMedCentral
17.
go back to reference Contou D, Canoui-Poitrine F, Coudroy R, Préau S, Cour M, Barbier F, et al. Long-term quality of life in adult patients surviving purpura fulminans: an exposed-unexposed multicenter cohort study. Clin Infect Dis. 2019;69:332–40.CrossRefPubMed Contou D, Canoui-Poitrine F, Coudroy R, Préau S, Cour M, Barbier F, et al. Long-term quality of life in adult patients surviving purpura fulminans: an exposed-unexposed multicenter cohort study. Clin Infect Dis. 2019;69:332–40.CrossRefPubMed
18.
go back to reference Herridge MS, Chu LM, Matte A, Tomlinson G, Chan L, Thomas C, et al. The RECOVER program: disability risk groups and 1-year outcome after 7 or more days of mechanical ventilation. Am J Respir Crit Care Med. 2016;194:831–44.CrossRefPubMed Herridge MS, Chu LM, Matte A, Tomlinson G, Chan L, Thomas C, et al. The RECOVER program: disability risk groups and 1-year outcome after 7 or more days of mechanical ventilation. Am J Respir Crit Care Med. 2016;194:831–44.CrossRefPubMed
19.
go back to reference Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.CrossRefPubMed Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.CrossRefPubMed
20.
go back to reference St-Louis E, Iqbal S, Feldman LS, Sudarshan M, Deckelbaum DL, Razek TS, et al. Using the age-adjusted Charlson comorbidity index to predict outcomes in emergency general surgery. J Trauma Acute Care Surg. 2015;78:318–23.CrossRefPubMed St-Louis E, Iqbal S, Feldman LS, Sudarshan M, Deckelbaum DL, Razek TS, et al. Using the age-adjusted Charlson comorbidity index to predict outcomes in emergency general surgery. J Trauma Acute Care Surg. 2015;78:318–23.CrossRefPubMed
21.
go back to reference Marchena-Gomez J, Acosta-Merida MA, Hemmersbach-Miller M, Conde-Martel A, Roque-Castellano C, Hernandez-Romero J. The age-adjusted Charlson Comorbidity Index as an outcome predictor of patients with acute mesenteric ischemia. Ann Vasc Surg. 2009;23:458–64.CrossRefPubMed Marchena-Gomez J, Acosta-Merida MA, Hemmersbach-Miller M, Conde-Martel A, Roque-Castellano C, Hernandez-Romero J. The age-adjusted Charlson Comorbidity Index as an outcome predictor of patients with acute mesenteric ischemia. Ann Vasc Surg. 2009;23:458–64.CrossRefPubMed
22.
go back to reference Legrand M, Hollinger A, Vieillard-Baron A, Dépret F, Cariou A, Deye N, et al. One-year prognosis of kidney injury at discharge from the ICU: a multicenter observational study. Crit Care Med. 2019;47:e953–61.CrossRefPubMed Legrand M, Hollinger A, Vieillard-Baron A, Dépret F, Cariou A, Deye N, et al. One-year prognosis of kidney injury at discharge from the ICU: a multicenter observational study. Crit Care Med. 2019;47:e953–61.CrossRefPubMed
23.
go back to reference Lemasle L, Blet A, Geven C, Cherifa M, Deniau B, Hollinger A, et al. Bioactive adrenomedullin, organ support therapies, and survival in the critically Ill: results from the french and european outcome registry in ICU study. Crit Care Med. 2020;48:49–55.CrossRefPubMed Lemasle L, Blet A, Geven C, Cherifa M, Deniau B, Hollinger A, et al. Bioactive adrenomedullin, organ support therapies, and survival in the critically Ill: results from the french and european outcome registry in ICU study. Crit Care Med. 2020;48:49–55.CrossRefPubMed
24.
go back to reference Takagi K, Blet A, Levy B, Deniau B, Azibani F, Feliot E, et al. Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial. Eur J Heart Fail. 2020;22:279–86.CrossRefPubMed Takagi K, Blet A, Levy B, Deniau B, Azibani F, Feliot E, et al. Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial. Eur J Heart Fail. 2020;22:279–86.CrossRefPubMed
25.
go back to reference Shankar-Hari M, Rubenfeld GD, Ferrando-Vivas P, Harrison DA, Rowan K. Development, validation, and clinical utility assessment of a prognostic score for 1-year unplanned rehospitalization or death of adult sepsis survivors. JAMA Netw Open. 2020;3:e2013-580.CrossRef Shankar-Hari M, Rubenfeld GD, Ferrando-Vivas P, Harrison DA, Rowan K. Development, validation, and clinical utility assessment of a prognostic score for 1-year unplanned rehospitalization or death of adult sepsis survivors. JAMA Netw Open. 2020;3:e2013-580.CrossRef
26.
go back to reference Li T, Hutfless S, Scharfstein DO, Daniels MJ, Hogan JW, Little RJA, et al. Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus. J Clin Epidemiol. 2014;67:15–32.CrossRefPubMedPubMedCentral Li T, Hutfless S, Scharfstein DO, Daniels MJ, Hogan JW, Little RJA, et al. Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus. J Clin Epidemiol. 2014;67:15–32.CrossRefPubMedPubMedCentral
28.
go back to reference Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763–8.CrossRefPubMed Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763–8.CrossRefPubMed
29.
go back to reference Seymour CW, Kerti SJ, Lewis AJ, Kennedy J, Brant E, Griepentrog JE, et al. Murine sepsis phenotypes and differential treatment effects in a randomized trial of prompt antibiotics and fluids. Crit Care. 2019;23:384.CrossRefPubMedPubMedCentral Seymour CW, Kerti SJ, Lewis AJ, Kennedy J, Brant E, Griepentrog JE, et al. Murine sepsis phenotypes and differential treatment effects in a randomized trial of prompt antibiotics and fluids. Crit Care. 2019;23:384.CrossRefPubMedPubMedCentral
30.
go back to reference Basagaña X, Barrera-Gómez J, Benet M, Antó JM, Garcia-Aymerich J. A framework for multiple imputation in cluster analysis. Am J Epidemiol. 2013;177:718–25.CrossRefPubMed Basagaña X, Barrera-Gómez J, Benet M, Antó JM, Garcia-Aymerich J. A framework for multiple imputation in cluster analysis. Am J Epidemiol. 2013;177:718–25.CrossRefPubMed
31.
go back to reference Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2:611–20.CrossRefPubMedPubMedCentral Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2:611–20.CrossRefPubMedPubMedCentral
32.
go back to reference Puthucheary ZA, Gensichen JS, Cakiroglu AS, Cashmore R, Edbrooke L, Heintze C, et al. Implications for post critical illness trial design: sub-phenotyping trajectories of functional recovery among sepsis survivors. Crit Care. 2020;24:577.CrossRefPubMedPubMedCentral Puthucheary ZA, Gensichen JS, Cakiroglu AS, Cashmore R, Edbrooke L, Heintze C, et al. Implications for post critical illness trial design: sub-phenotyping trajectories of functional recovery among sepsis survivors. Crit Care. 2020;24:577.CrossRefPubMedPubMedCentral
33.
go back to reference Soussi S, Collins GS, Jüni P, Mebazaa A, Gayat E, Le Manach Y. Evaluation of biomarkers in critical care and perioperative medicine: a clinician’s overview of traditional statistical methods and machine learning algorithms. Anesthesiology. 2021;134:15–25.CrossRefPubMed Soussi S, Collins GS, Jüni P, Mebazaa A, Gayat E, Le Manach Y. Evaluation of biomarkers in critical care and perioperative medicine: a clinician’s overview of traditional statistical methods and machine learning algorithms. Anesthesiology. 2021;134:15–25.CrossRefPubMed
34.
go back to reference Prescott HC, Langa KM, Iwashyna TJ. Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions. JAMA. 2015;313:1055–7.CrossRefPubMedPubMedCentral Prescott HC, Langa KM, Iwashyna TJ. Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions. JAMA. 2015;313:1055–7.CrossRefPubMedPubMedCentral
35.
37.
go back to reference Hoogwerf BJ. Renin-angiotensin system blockade and cardiovascular and renal protection. Am J Cardiol. 2010;105:30A-A35.CrossRefPubMed Hoogwerf BJ. Renin-angiotensin system blockade and cardiovascular and renal protection. Am J Cardiol. 2010;105:30A-A35.CrossRefPubMed
38.
go back to reference Hsu W-T, Galm BP, Schrank G, Hsu T-C, Lee S-H, Park JY, et al. Effect of renin-angiotensin-aldosterone system inhibitors on short-term mortality after sepsis: a population-based cohort study. Hypertension. 2020;75:483–91.CrossRefPubMed Hsu W-T, Galm BP, Schrank G, Hsu T-C, Lee S-H, Park JY, et al. Effect of renin-angiotensin-aldosterone system inhibitors on short-term mortality after sepsis: a population-based cohort study. Hypertension. 2020;75:483–91.CrossRefPubMed
39.
go back to reference Gayat E, Hollinger A, Cariou A, Deye N, Vieillard-Baron A, Jaber S, et al. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury. Intensive Care Med. 2018;44:598–605.CrossRefPubMed Gayat E, Hollinger A, Cariou A, Deye N, Vieillard-Baron A, Jaber S, et al. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury. Intensive Care Med. 2018;44:598–605.CrossRefPubMed
Metadata
Title
Identifying clinical subtypes in sepsis-survivors with different one-year outcomes: a secondary latent class analysis of the FROG-ICU cohort
Authors
Sabri Soussi
Divya Sharma
Peter Jüni
Gerald Lebovic
Laurent Brochard
John C. Marshall
Patrick R. Lawler
Margaret Herridge
Niall Ferguson
Lorenzo Del Sorbo
Elodie Feliot
Alexandre Mebazaa
Erica Acton
Jason N. Kennedy
Wei Xu
Etienne Gayat
Claudia C. Dos Santos
the FROG-ICU
CCCTBG trans-trial group study for InFACT - the International Forum for Acute Care Trialists
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2022
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-022-03972-8

Other articles of this Issue 1/2022

Critical Care 1/2022 Go to the issue